Ownership history in Continuum Advisory, LLC · 9 quarters on record
This page tracks every 13F SEC filing in which Continuum Advisory, LLC reported a position in GSK PLC (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 5,671 | -1,285 | -18.5% | 0.03% | $245K | $42.44 |
| 2025 Q2 | REDUCED | 6,956 | -4,973 | -41.7% | 0.03% | $267K | $37.35 |
| 2025 Q1 | REDUCED | 11,929 | -151 | -1.2% | 0.06% | $462K | $37.25 |
| 2024 Q4 | ADDED | 12,080 | +1,481 | +14.0% | 0.05% | $409K | $32.17 |
| 2024 Q3 | ADDED | 10,599 | +487 | +4.8% | 0.05% | $364K | $38.44 |
| 2024 Q2 | ADDED | 10,112 | +52 | +0.5% | 0.06% | $389K | $35.87 |
| 2024 Q1 | REDUCED | 10,060 | -6,925 | -40.8% | 0.07% | $449K | $39.61 |
| 2023 Q4 | ADDED | 16,985 | +3,094 | +22.3% | 0.09% | $630K | $33.91 |
| 2023 Q3 | INITIATED | 13,891 | — | — | 0.08% | $504K | — |
As of 2025 Q4 — sorted by position size